We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$717M
AUM Growth
+$27.3M
Cap. Flow
+$32.6M
Cap. Flow %
4.54%
Top 10 Hldgs %
29.66%
Holding
2,758
New
211
Increased
1,430
Reduced
492
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 12.64%
2 Consumer Staples 8%
3 Financials 7.08%
4 Consumer Discretionary 6.44%
5 Healthcare 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SILK
2426
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1K ﹤0.01%
+11
New +$576
AMK
2427
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$1K ﹤0.01%
+53
New +$1.37K
ATRI
2428
DELISTED
Atrion Corp
ATRI
$1K ﹤0.01%
+2
New +$1.33K
LL
2429
DELISTED
LL Flooring Holdings, Inc.
LL
$1K ﹤0.01%
73
DCPH
2430
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1K ﹤0.01%
+29
New +$926
NGM
2431
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1K ﹤0.01%
+25
New +$550
KNTE
2432
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1K ﹤0.01%
+22
New +$479
BCEL
2433
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1K ﹤0.01%
+87
New +$580
VAPO
2434
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1K ﹤0.01%
+3
New +$610
TRTN
2435
DELISTED
Triton International Limited
TRTN
$1K ﹤0.01%
15
+4
+36% +$208
RETA
2436
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1K ﹤0.01%
13
NUVA
2437
DELISTED
NuVasive, Inc.
NUVA
$1K ﹤0.01%
13
+9
+225% +$555
SPPI
2438
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
301
-1,995
-87% -$5.45K
ROCC
2439
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1K ﹤0.01%
+39
New +$767
RUTH
2440
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$1K ﹤0.01%
65
DBD
2441
DELISTED
Diebold Nixdorf Incorporated
DBD
$1K ﹤0.01%
90
BRMK
2442
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$1K ﹤0.01%
128
+116
+967% +$1.21K
RIDE
2443
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$1K ﹤0.01%
+6
New +$624
AUD
2444
DELISTED
Audacy, Inc.
AUD
$1K ﹤0.01%
+171
New +$599
SI
2445
DELISTED
Silvergate Capital Corporation
SI
$1K ﹤0.01%
5
PRVB
2446
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
147
+125
+568% +$803
AUY
2447
DELISTED
Yamana Gold, Inc.
AUY
$1K ﹤0.01%
166
-432
-72% -$1.83K
PAYA
2448
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$1K ﹤0.01%
+88
New +$949
TEN
2449
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1K ﹤0.01%
57
-13
-19% -$210
QTNT
2450
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1K ﹤0.01%
8
-11
-58% -$1.37K

Similar funds

Quadrant Capital Group's Q3 2021 Portfolio in Review

As of Q3 2021, Quadrant Capital Group held 2,758 positions worth $717M, up 4% from $689M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $32.6M of net new capital in Q3 2021, opening 211 new positions and adding to 1,430 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Hillenbrand, an estimated $571K trimmed.

  • Quadrant Capital Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.
  • Quadrant Capital Group added most to iShares Russell 1000 ETF in Q3 2021, an estimated $2.03M increase.
  • Quadrant Capital Group's biggest Q3 2021 reduction was Hillenbrand, cutting an estimated $571K.
  • Quadrant Capital Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $235K.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $717M portfolio in Q3 2021.
  • Quadrant Capital Group opened 211 new positions and closed 124 in Q3 2021.
  • Quadrant Capital Group's portfolio value rose 4% quarter-over-quarter to $717M.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.